Macalline announced that the cumulative deviation value of the company's stock price increase reached 20% for three consecutive trading days from December 8 to 10, 2025, which is an abnormal fluctuation. After self-inspection, the company is operating normally, and no important information should be disclosed. Revenue in 2024 was 7.82 billion yuan, down 32.08% year on year, net profit - 2.98 billion yuan; revenue for the first three quarters of 2025 was 4.97 billion yuan, down 18.62% year on year, and net profit - 3.14 billion yuan. In addition, Hangzhou Haoyue, a shareholder holding more than 5% of the shares, has plans to reduce their holdings and has not yet begun to reduce their holdings. The company reminds investors to be aware of the risk of loss of trading and performance.

Macalline announced that the cumulative deviation value of the company's stock price increase reached 20% for three consecutive trading days from December 8 to 10, 2025, which is an abnormal fluctuation. After self-inspection, the company is operating normally, and no important information should be disclosed. Revenue in 2024 was 7.82 billion yuan, down 32.08% year on year, net profit - 2.98 billion yuan; revenue for the first three quarters of 2025 was 4.97 billion yuan, down 18.62% year on year, and net profit - 3.14 billion yuan. In addition, Hangzhou Haoyue, a shareholder holding more than 5% of the shares, has plans to reduce their holdings and has not yet begun to reduce their holdings. The company reminds investors to be aware of the risk of loss of trading and performance.